|
|
||||||||
Departments of Nuclear Medicine, Medicine and Clinical Physiology, and Radiochemistry Laboratory, University of Turku, Turku; Turku PET Centre, Turku, Finland
Correspondence: For correspondence or reprints contact: Maija T. Mäki, MD, Turku PET Centre, University of Turku, FIN-20520, Turku, Finland.
ABSTRACT
14(R,S)-[18F]fluoro-6-thia-heptadecanoic acid (FTHA) has been recently introduced as a new tracer for fatty acid metabolism. Myocardial [18F]FTHA uptake is believed to reflect mainly beta-oxidation of the circulating free fatty acids (FFAs), since it is trapped in the mitochondria because subsequent steps of beta-oxidation are inhibited by sulfur heteroatom. We investigated [18F]FTHA kinetics in myocardial and skeletal muscle in vivo. Methods: Two dynamic PET studies were performed in seven patients with stable coronary artery disease, once in the fasting state and once during euglycemic hyperinsulinemia (serum insulin
60 mU/liter). The fractional [18F] FTHA uptake rates (Ki) were multiplied with serum FFA concentra tions and were considered to represent FFA uptake. Results: Serum FFA concentration decreased by 80% during insulin clamp. After tracer injection, rapid myocardial uptake was identified both in the fasting state and during insulin stimulation. The cardiac image quality was excellent in both occasions. In addition, femoral muscles were clearly visualized in both studies. The fractional myocardial [18F]FTHA uptake rates (Ki) in the normal myocardial regions were similar in the fasting state (0.11 ± 0.04 ml/g/min (mean ± s.d.) and during insulin clamp (0.12 ± 0.03 ml/g/min;ns). The calculated myocardial FFA uptake was four times higher in the fasting state than during insulin clamp (5.8 ± 1.7 versus 1.4 ± 0.5 /xmol/100 g/min, p < 0.005). The femoral muscle fractional [18F]FTHA uptake rates (Ki) were lower (0.0071 ± 0.0014 ml/g/min) in the fasting state than during insulin clamp (0.0127 ± 0.0036 ml/g/min;p = 0.03), but the estimated femoral muscle FFA uptake was three times higher in the fasting state (0.38 ± 0.09 /u.mol/100 g/min) as compared to that during insulin clamp (0.12 ± 0.05 µmol/100 g/min, p < 0.005). Conclusion: Fluorine-18-FTHA PET appears to be a feasible method to estimate fatty acid kinetics in myocardial and skeletal muscle. Physiologically reasonable rates of FFA uptake in myocardium and skeletal muscle were obtained. Furthermore, the uptake rates were suppressed in response to insulin both in the myocardial and femoral muscle as expected.
Key Words: free fatty acids fluorine-18-fluoro-6-thia-heptade-canoic acid muscle myocardium PET
This article has been cited by other articles:
![]() |
M. G. Clark Impaired microvascular perfusion: a consequence of vascular dysfunction and a potential cause of insulin resistance in muscle Am J Physiol Endocrinol Metab, October 1, 2008; 295(4): E732 - E750. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Guiducci, T. Gronroos, M. J. Jarvisalo, J. Kiss, A. Viljanen, A. G. Naum, T. Viljanen, T. Savunen, J. Knuuti, E. Ferrannini, et al. Biodistribution of the Fatty Acid Analogue 18F-FTHA: Plasma and Tissue Partitioning Between Lipid Pools During Fasting and Hyperinsulinemia J. Nucl. Med., March 1, 2007; 48(3): 455 - 462. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Hannukainen, P. Nuutila, B. Ronald, J. Kaprio, U. M. Kujala, T. Janatuinen, O. J. Heinonen, J. Kapanen, T. Viljanen, M. Haaparanta, et al. Increased physical activity decreases hepatic free fatty acid uptake: a study in human monozygotic twins J. Physiol., January 1, 2007; 578(1): 347 - 358. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Hannukainen, P. Nuutila, J. Kaprio, O. J Heinonen, U. M. Kujala, T. Janatuinen, T. Ronnemaa, J. Kapanen, M. Haaparanta-Solin, T. Viljanen, et al. Relationship between local perfusion and FFA uptake in human skeletal muscle--no effect of increased physical activity and aerobic fitness J Appl Physiol, November 1, 2006; 101(5): 1303 - 1311. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Shearer, P. T. Fueger, J. N. Rottman, D. P. Bracy, P. H. Martin, and D. H. Wasserman AMPK stimulation increases LCFA but not glucose clearance in cardiac muscle in vivo Am J Physiol Endocrinol Metab, November 1, 2004; 287(5): E871 - E877. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Iozzo, T. Takala, V. Oikonen, J. Bergman, T. Gronroos, E. Ferrannini, P. Nuutila, and J. Knuuti Effect of Training Status on Regional Disposal of Circulating Free Fatty Acids in the Liver and Skeletal Muscle During Physiological Hyperinsulinemia Diabetes Care, September 1, 2004; 27(9): 2172 - 2177. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Iozzo, A. K. Turpeinen, T. Takala, V. Oikonen, J. Bergman, T. Gronroos, E. Ferrannini, P. Nuutila, and J. Knuuti Defective Liver Disposal of Free Fatty Acids in Patients with Impaired Glucose Tolerance J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3496 - 3502. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. N. Rottman, D. Bracy, C. Malabanan, Z. Yue, J. Clanton, and D. H. Wasserman Contrasting effects of exercise and NOS inhibition on tissue-specific fatty acid and glucose uptake in mice Am J Physiol Endocrinol Metab, July 1, 2002; 283(1): E116 - E123. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. R. Wallhaus, M. Taylor, T. R. DeGrado, D. C. Russell, P. Stanko, R. J. Nickles, and C. K. Stone Myocardial Free Fatty Acid and Glucose Use After Carvedilol Treatment in Patients With Congestive Heart Failure Circulation, May 22, 2001; 103(20): 2441 - 2446. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Taylor, T. R. Wallhaus, T. R. DeGrado, D. C. Russell, P. Stanko, R. J. Nickles, and C. K. Stone An Evaluation of Myocardial Fatty Acid and Glucose Uptake Using PET with [18F]Fluoro-6-Thia-Heptadecanoic Acid and [18F]FDG in Patients with Congestive Heart Failure J. Nucl. Med., January 1, 2001; 42(1): 55 - 62. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. O. Takala, P. Nuutila, C. Katoh, M. Luotolahti, J. Bergman, M. Maki, V. Oikonen, U. Ruotsalainen, T. Gronroos, M. Haaparanta, et al. Myocardial blood flow, oxygen consumption, and fatty acid uptake in endurance athletes during insulin stimulation Am J Physiol Endocrinol Metab, October 1, 1999; 277(4): E585 - E590. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. O. Takala, P. Nuutila, J. Knuuti, M. Luotolahti, and H. Yki-Jarvinen Insulin action on heart and skeletal muscle glucose uptake in weight lifters and endurance athletes Am J Physiol Endocrinol Metab, April 1, 1999; 276(4): E706 - E711. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |